D Falch

598 total citations
26 papers, 455 citations indexed

About

D Falch is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D Falch has authored 26 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D Falch's work include Blood Pressure and Hypertension Studies (4 papers), Magnesium in Health and Disease (4 papers) and Hemodynamic Monitoring and Therapy (4 papers). D Falch is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Magnesium in Health and Disease (4 papers) and Hemodynamic Monitoring and Therapy (4 papers). D Falch collaborates with scholars based in Norway, United Kingdom and United States. D Falch's co-authors include Nils Norman, A. E Ödegaard, Lars Gullestad, A. Schreiner, L. Ø. Dolva, John Kjekshus, K. Rootwelt, Arne N. Teien, Frode Fonnum and Lars Gullestad and has published in prestigious journals such as Diabetes, The American Journal of Cardiology and Alcoholism Clinical and Experimental Research.

In The Last Decade

D Falch

23 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Falch Norway 13 103 95 95 90 84 26 455
J H Bauer United States 12 192 1.9× 39 0.4× 70 0.7× 137 1.5× 93 1.1× 19 396
D. Gordon United Kingdom 13 182 1.8× 86 0.9× 100 1.1× 47 0.5× 190 2.3× 24 614
A.I. Macdougall United Kingdom 12 42 0.4× 124 1.3× 66 0.7× 76 0.8× 53 0.6× 20 512
G. Kolsters Netherlands 11 198 1.9× 92 1.0× 94 1.0× 218 2.4× 120 1.4× 18 541
P Cottier Switzerland 8 95 0.9× 59 0.6× 99 1.0× 96 1.1× 65 0.8× 39 335
Peart Ws United Kingdom 10 166 1.6× 38 0.4× 95 1.0× 86 1.0× 89 1.1× 32 513
Hollenberg Nk United States 14 199 1.9× 42 0.4× 129 1.4× 110 1.2× 92 1.1× 32 579
Ch. Schnack Austria 14 200 1.9× 62 0.7× 68 0.7× 113 1.3× 154 1.8× 20 500
J. S. McNeil United States 15 55 0.5× 113 1.2× 61 0.6× 184 2.0× 45 0.5× 19 624
M J Weston United Kingdom 10 62 0.6× 186 2.0× 59 0.6× 99 1.1× 32 0.4× 19 427

Countries citing papers authored by D Falch

Since Specialization
Citations

This map shows the geographic impact of D Falch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Falch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Falch more than expected).

Fields of papers citing papers by D Falch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Falch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Falch. The network helps show where D Falch may publish in the future.

Co-authorship network of co-authors of D Falch

This figure shows the co-authorship network connecting the top 25 collaborators of D Falch. A scholar is included among the top collaborators of D Falch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Falch. D Falch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Flesland, Ø, et al.. (2004). Transferrin receptor in serum. A new tool in the diagnosis and prevention of iron deficiency in blood donors. Transfusion and Apheresis Science. 31(1). 11–16. 21 indexed citations
2.
Torsvik, Harald, et al.. (2002). Effect of morning versus evening intake of simvastatin on the serum cholesterol level in patients with coronary artery disease. The American Journal of Cardiology. 90(7). 784–786. 26 indexed citations
3.
Gullestad, Lars, et al.. (1994). Magnesium status in healthy free-living elderly Norwegians.. Journal of the American College of Nutrition. 13(1). 45–50. 31 indexed citations
4.
Gullestad, Lars, et al.. (1992). Magnesium deficiency diagnosed by an intravenous loading test. Scandinavian Journal of Clinical and Laboratory Investigation. 52(4). 245–253. 39 indexed citations
5.
Opstad, P. K., D Falch, Olav Øktedalen, Frode Fonnum, & Ragnhild Wergeland. (1984). THE THYROID FUNCTION IN YOUNG MEN DURING PROLONGED EXERCISE AND THE EFFECT OF ENERGY AND SLEEP DEPRIVATION. Clinical Endocrinology. 20(6). 657–669. 37 indexed citations
6.
Falch, D & A. Schreiner. (1983). The Effect of Spironolactone on Lipid, Glucose and Uric Acid Levels in Blood during Long‐Term Administration to Hypertensives. Acta Medica Scandinavica. 213(1). 27–30. 30 indexed citations
7.
Falch, D, Johan Sundsfjord, & Nils Norman. (1981). The Influence of Dihydralazine and Angiotensin-II Blockade on Renal Extraction of [131I]Hippuran. Scandinavian Journal of Urology and Nephrology. 15(2). 127–130.
8.
Rootwelt, K., et al.. (1980). Determination of glomerular filtration rate (GFR) by analysis of capillary blood after single shot injection of 99mTc-DTPA. European Journal of Nuclear Medicine and Molecular Imaging. 5(2). 97–102. 32 indexed citations
9.
Falch, D, et al.. (1979). Pulmonary blood volume and interventricular circulation time in physically trained and untrained subjects. European Journal of Applied Physiology. 40(3). 211–218. 12 indexed citations
10.
Falch, D, A. E Ödegaard, & Nils Norman. (1979). Decreased Renal Plasma Flow during Propranolol Treatment in Essential Hypertension. Acta Medica Scandinavica. 205(1-6). 91–95. 22 indexed citations
11.
Falch, D, Rolf Johansson, A. E Ödegaard, & Nils Norman. (1979). Haemodynamic effects of treatment and withdrawal of spironolactone in essential hypertension. Scandinavian Journal of Clinical and Laboratory Investigation. 39(2). 159–165. 6 indexed citations
12.
Falch, D, A. E Ödegaard, & Nils Norman. (1978). Renal plasma flow and cardiac output during hydralazine and propranolol treatment in essential hypertension. Scandinavian Journal of Clinical and Laboratory Investigation. 38(2). 143–146. 41 indexed citations
13.
Falch, D, et al.. (1978). 113mIn-DTPA, a useful compound for the determination of glomerular filtration rate (GFR). European Journal of Nuclear Medicine and Molecular Imaging. 3(3). 179–81. 9 indexed citations
14.
Falch, D & Nils Norman. (1974). Evaluation of a Computerized Technique for Determination of Cardiac Output and Central Circulation Times Using Gamma Camera and 113mIndium. Scandinavian Journal of Clinical and Laboratory Investigation. 34(3). 207–214. 4 indexed citations
15.
Falch, D & Nils Norman. (1974). Evaluation of a Computerized Technique for Determination of Cardiac Output and Central Circulation Times Using Gamma Camera and113mIndium. Scandinavian Journal of Clinical and Laboratory Investigation. 34(3). 207–214. 8 indexed citations
16.
17.
Falch, D. (1973). THE INFLUENCE OF KIDNEY FUNCTION, BODY SIZE AND AGE ON PLASMA CONCENTRATION AND URINARY EXCRETION OF DIGOXIN. Acta Medica Scandinavica. 194(1-6). 251–256. 17 indexed citations
18.
Falch, D. (1973). Determination of digoxin in plasma by radioimmunoassay.. PubMed. 23(2). 35–46. 1 indexed citations
19.
Forfang, Kolbjørn, et al.. (1973). CHRONIC CONGESTIVE HEART FAILURE TREATED WITH LONG‐TERM INFUSION OF GLUCAGON. Acta Medica Scandinavica. 194(1-6). 563–566. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026